Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

Local Insights: The Role of Life Science Consulting in Eastvale's Healthcare Sector

Jun 12, 2025

Understanding the Importance of Life Science Consulting

Eastvale's healthcare sector is evolving rapidly, and life science consulting is playing a pivotal role in driving this transformation. By providing specialized expertise, these consultants help healthcare providers in Eastvale enhance their operations, optimize patient care, and stay compliant with regulatory requirements. As the healthcare landscape continues to grow, the demand for life science consulting services is becoming increasingly crucial.

life science consulting

Life science consultants bring a wealth of knowledge and experience to the table, offering strategic insights that can lead to improved healthcare practices and innovative solutions. Their expertise spans across various domains, including pharmaceuticals, biotechnology, and medical devices, ensuring that healthcare providers in Eastvale are well-equipped to meet modern challenges.

Enhancing Healthcare Delivery

One of the primary contributions of life science consulting in Eastvale is the enhancement of healthcare delivery. Consultants work closely with healthcare institutions to streamline processes, implement cutting-edge technologies, and introduce best practices that lead to more efficient and effective patient care. This collaboration not only improves patient outcomes but also enhances the overall experience for healthcare professionals.

healthcare technology

Moreover, life science consultants are instrumental in helping healthcare organizations adopt new technologies such as telemedicine, electronic health records, and AI-driven diagnostic tools. By integrating these advancements, Eastvale's healthcare sector can offer more personalized and accessible care to its residents.

Regulatory Compliance and Risk Management

Navigating the complex web of regulations in the healthcare industry can be daunting. Life science consultants provide invaluable assistance in ensuring that healthcare providers in Eastvale remain compliant with ever-changing regulations. They offer guidance on clinical trials, data protection, and quality assurance, helping organizations mitigate risks and avoid costly penalties.

healthcare compliance

Consultants also play a key role in risk management by identifying potential vulnerabilities within healthcare systems and implementing strategies to address them. This proactive approach not only safeguards patient data but also protects the reputation of healthcare institutions.

Driving Innovation and Growth

Innovation is at the heart of life science consulting. By fostering a culture of innovation, consultants enable healthcare providers in Eastvale to explore new opportunities for growth and development. This includes conducting market research, identifying emerging trends, and developing strategies to capitalize on these trends.

healthcare innovation

The collaboration between life science consultants and healthcare organizations often results in the development of new products, services, or treatments that can significantly impact patient care. As a result, Eastvale's healthcare sector is well-positioned to thrive in a competitive landscape.

The Future of Life Science Consulting in Eastvale

As Eastvale's healthcare sector continues to expand, the role of life science consulting will only become more integral. By providing expert guidance and fostering innovation, these consultants are helping shape a future where healthcare is more efficient, effective, and patient-centered. With their support, Eastvale is poised to become a leader in delivering high-quality healthcare services.